PMVP - PMV Pharmaceuticals, Inc

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.42 0.05 (3.27%) --- --- --- 0.04 (2.82%) 0.03 (1.76%) 0.05 (3.27%) 0.05 (3.27%)

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.41
Diluted EPS:
-0.41
Basic P/E:
-3.5766
Diluted P/E:
-3.5766
RSI(14) 1m:
58.0
VWAP:
1.46
RVol:

Events

Period Kind Movement Occurred At

Related News